Back to Search Start Over

Research Advances in Clinical Applications, Anticancer Mechanism, Total Chemical Synthesis, Semi-Synthesis and Biosynthesis of Paclitaxel

Authors :
Shengnan Zhang
Taiqiang Ye
Yibin Liu
Guige Hou
Qibao Wang
Fenglan Zhao
Feng Li
Qingguo Meng
Source :
Molecules, Vol 28, Iss 22, p 7517 (2023)
Publication Year :
2023
Publisher :
MDPI AG, 2023.

Abstract

Paclitaxel, a natural secondary metabolite isolated and purified from the bark of the Taxus tree, is considered one of the most successful natural anticancer drugs due to its low toxicity, high potency and broad-spectrum anticancer activity. Taxus trees are scarce and slow-growing, and with extremely low paclitaxel content, the contradiction between supply and demand in the market is becoming more and more intense. Therefore, researchers have tried to obtain paclitaxel by various methods such as chemical synthesis, artificial culture, microbial fermentation and tissue cell culture to meet the clinical demand for this drug. This paper provides a comprehensive overview of paclitaxel extraction, combination therapy, total synthesis, semi-synthesis and biosynthesis in recent years and provides an outlook, aiming to provide a theoretical basis and reference for further research on the production and application of paclitaxel in the future.

Details

Language :
English
ISSN :
14203049
Volume :
28
Issue :
22
Database :
Directory of Open Access Journals
Journal :
Molecules
Publication Type :
Academic Journal
Accession number :
edsdoj.5a7668a59b3d4d3791bc246859b8e020
Document Type :
article
Full Text :
https://doi.org/10.3390/molecules28227517